 |
|
The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?
Dora M. Gorman (Gorman DM), Carel W. le Roux (le Roux CW), Neil G. Docherty (Docherty NG)
Diabetes Metab J. 2016;40(5):354-364. Published online 2016 Sep 27 DOI: https://doi.org/10.4093/dmj.2016.40.5.354
|
|
Citations to this article as recorded by
 Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates
Kalie L. Tommerdahl, Allison L. B. Shapiro, Edward J. Nehus, Petter Bjornstad
Pediatric Nephrology.2022; 37(1): 79. CrossRef New Insights into Treating Early and Advanced Stage Diabetic Retinopathy
Rafael Simó, Cristina Hernández
International Journal of Molecular Sciences.2022; 23(15): 8513. CrossRef Response to Letter to the Editor Concerning: Adam S. et al. Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort Study
Safwaan Adam, Jan Hoong Ho, Akheel A. Syed, Rayaz A. Malik, Handrean Soran
Obesity Surgery.2022; 32(10): 3460. CrossRef Weight management and multi-morbidity
Carrie Ashby
InnovAiT: Education and inspiration for general practice.2021; 14(8): 523. CrossRef The Safety of Pharmacological and Surgical Treatment of Diabetes in Patients with Diabetic Retinopathy—A Review
Wojciech Matuszewski, Angelika Baranowska-Jurkun, Magdalena Maria Stefanowicz-Rutkowska, Katarzyna Gontarz-Nowak, Ewa Gątarska, Elżbieta Bandurska-Stankiewicz
Journal of Clinical Medicine.2021; 10(4): 705. CrossRef Safety of Semaglutide
Mark M. Smits, Daniël H. Van Raalte
Frontiers in Endocrinology.2021;[Epub] CrossRef Outcomes of Diabetic Retinopathy Post-Bariatric Surgery in Patients with Type 2 Diabetes Mellitus
Ana Maria Dascalu, Anca Pantea Stoian, Alina Popa Cherecheanu, Dragos Serban, Daniel Ovidiu Costea, Mihail Silviu Tudosie, Daniela Stana, Denisa Tanasescu, Alexandru Dan Sabau, Gabriel Andrei Gangura, Andreea Cristina Costea, Vanessa Andrada Nicolae, Cata
Journal of Clinical Medicine.2021; 10(16): 3736. CrossRef Future perspectives in diabesity treatment: Semaglutide, a glucagon‑like peptide 1 receptor agonist (Review)
Mariana Tilinca, Robert Tiuca, Cristina Niculas, Andreea Varga, Ioan Tilea
Experimental and Therapeutic Medicine.2021;[Epub] CrossRef Safety of injectable semaglutide for type 2 diabetes
Rajesh Peter, Steve C. Bain
Expert Opinion on Drug Safety.2020; 19(7): 785. CrossRef Early worsening of diabetic retinopathy due to intensive glycaemic control
Shueh Wen Lim, Peter van Wijngaarden, Colin A. Harper, Salmaan H. Al‐Qureshi
Clinical & Experimental Ophthalmology.2019; 47(2): 265. CrossRef Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review
Stephen C. Bain, Michael A. Klufas, Allen Ho, David R. Matthews
Diabetes, Obesity and Metabolism.2019; 21(3): 454. CrossRef Diabetische Retinopathie bei Patienten mit Diabetes mellitus
Olga Simó-Servat, Cristina Hernández, Rafael Simó
Kompass Ophthalmologie.2019; 5(4): 157. CrossRef Diabetic Retinopathy in the Context of Patients with Diabetes
Olga Simó-Servat, Cristina Hernández, Rafael Simó
Ophthalmic Research.2019; 62(4): 211. CrossRef MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass
Adrian T Billeter, Javier R de la Garza Herrera, Katharina M Scheurlen, Felix Nickel, Franck Billmann, Beat P Müller-Stich
European Journal of Endocrinology.2018; 179(2): R77. CrossRef Aggravation précoce de la rétinopathie diabétique lors de l’optimisation du contrôle glycémique
S. Feldman-Billard
Médecine des Maladies Métaboliques.2018; 12(7): 560. CrossRef Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
Tina Vilsbøll, Stephen C. Bain, Lawrence A. Leiter, Ildiko Lingvay, David Matthews, Rafael Simó, Ida Carøe Helmark, Nelun Wijayasinghe, Michael Larsen
Diabetes, Obesity and Metabolism.2018; 20(4): 889. CrossRef Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy
Antonios Douros, Kristian B. Filion, Hui Yin, Oriana Hoi Yu, Mahyar Etminan, Jacob A. Udell, Laurent Azoulay
Diabetes Care.2018; 41(11): 2330. CrossRef Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes
S. Feldman-Billard, É. Larger, P. Massin
Diabetes & Metabolism.2018; 44(1): 4. CrossRef Excess visceral adiposity is associated with diabetic retinopathy in a multiethnic Asian cohort with longstanding type 2 diabetes
Angela Moh, Kumari Neelam, Xiao Zhang, Chee Fang Sum, Subramaniam Tavintharan, Keven Ang, Simon Biing Ming Lee, Wern Ee Tang, Su Chi Lim
Endocrine Research.2018; 43(3): 186. CrossRef GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe?
Rafael Simó, Cristina Hernández
Diabetes.2017; 66(6): 1453. CrossRef The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis
Binwu Sheng, Khoa Truong, Hugh Spitler, Lu Zhang, Xuetao Tong, Liwei Chen
Obesity Surgery.2017; 27(10): 2724. CrossRef Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy
M. A. Stefater, T. H. Inge
Current Diabetes Reports.2017;[Epub] CrossRef The role of bariatric surgery to treat diabetes: current challenges and perspectives
Chrysi Koliaki, Stavros Liatis, Carel W. le Roux, Alexander Kokkinos
BMC Endocrine Disorders.2017;[Epub] CrossRef
|